Skip to content
Home/Companies/MedTech/Blueprint Genetics

Blueprint Genetics

MedTech·Finland·Exited 2020·Held 3yr
Entry
2017
Hold
3yr
Exit
2020

Who owns Blueprint Genetics?

Blueprint Genetics was owned by Creathor Ventures through Creathor Venture Fund III (2012 vintage) from 2017 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Creathor Ventures
Investor
Creathor Ventures
Creathor Venture Fund III · 2012 · VC

Key facts

HQFinland
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from Creathor Venture Fund III

Other portfolio companies in the same fund.

Allthings Technologies
Allthings Technologies
Active
SoftwareSwitzerland· 2017
EchoRing (R3 Communications)
EchoRing (R3 Communications)
Active
Deep TechGermany· 2017
Humanoo
Active
HealthTechGermany· 2017
CryoTherapeutics
CryoTherapeutics
Active
MedTechBelgium· 2016
COBI
Exited 2017
MobilityGermany· 2015
to
Digital Insurance Group (Knip)
Active
FintechSwitzerland· 2015

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Blueprint Genetics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Blueprint Genetics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Blueprint Genetics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue